Please note the following funding opportunity announcements (via ScanGrants):
American Association for Cancer Research-National Brain Tumor Society Career Development Award for Translational Brain Tumor Research
Posted: 19 Nov 2012 08:39 AM PST
American Association for Cancer Research-National Brain Tumor Society Career Development Award for Translational Brain Tumor Research
Application deadline: November 30, 2012, at noon, ET
Decision date: March 2013
Annual Grants Reception and Dinner at AACR Annual Meeting 2013: April 9, 2013
Start of grant term: July 1, 2013
The AACR-National Brain Tumor Society Career Development Award for Translational Brain Tumor Research represents a joint effort to encourage and support junior faculty who are in the first 5 years of a faculty appointment (at the start of the grant term) to conduct brain tumor research and establish successful career paths in this field. The research proposed for funding must be translational in nature and have direct applicability and relevance to brain tumors.
The Award provides $150,000 over two years ($75,000 per year) for direct research expenses; which may include the salary and benefits of the grant recipient, postdoctoral or clinical research fellows, and/or research assistants, research/laboratory supplies and equipment.
It is anticipated that one award will be funded.
Applicant Eligibility Criteria
Applicants must have a doctoral degree (including Ph.D., M.D., D.O., D.C., N.D., D.D.S., D.V.M., Sc.D., D.N.S., Pharm.D., or equivalent doctoral degree, or a combined clinical and research doctoral degree) in a related field and not currently be a candidate for a further doctoral or professional degree.
At the start of the grant term on July 1, 2013, applicants must:
Hold a full-time faculty position with the title of instructor, research assistant professor, assistant professor, or an equivalent full-time faculty position
Have held a full-time faculty position or the equivalent for no more than five years (i.e., cannot have had a full-time faculty appointment before July 2, 2008)
Work at an academic, medical, or research institution within the United States. (There are no citizenship requirements; however, an applicant who is not a U.S. citizen or permanent resident, by submitting an application for this grant, assures that his/her visa status will provide sufficient time to complete the project and grant term within the United States.)
Employees or subcontractors of a government entity or for-profit private industry are not eligible. Exceptions include applicants holding full-time positions at a veterans' hospital or national laboratory (e.g., Lawrence Berkeley National Laboratory) in the United States. Contact AACR before submitting an application to determine your eligibility.
Both AACR members and nonmembers are eligible to apply. However, nonmembers must submit a satisfactory application for AACR active membership by December 4, 2012. The application will be applied to 2012 membership dues. Download a membership application.
Any individual who currently holds an active AACR grant may not apply. Past AACR grantees may apply if they complied with all progress and financial report requirements.
Individuals may concurrently apply for other AACR grants; should an applicant apply for multiple AACR grants, he/she is expected to accept the first grant awarded. Individuals may accept and hold only one AACR grant at a time.
Postdoctoral or clinical research fellows or the equivalent who are working under the auspices of a scientific mentor are not eligible to apply. Qualified fellows are invited to apply for an AACR Fellowship.
All applicants with questions about eligibility should contact AACR at [log in to unmask] before submitting an application.
2013 Prevention of Acquired Epilepsies Award
Posted: 19 Nov 2012 08:19 AM PST
2013 Prevention of Acquired Epilepsies Award
CURE seeks novel research projects of relevance to the prevention, treatment and cures of acquired (post-insult) epilepsies including: (1) the cellular, molecular, and systems-level understanding of the underlying pathogenic mechanisms; (2) specific approaches to modify the development of acquired epilepsy; (3) animal models of acquired epilepsy; and (4) investigations of the impact, natural history, and epidemiology of acquired epilepsy. For the purposes of this program, "acquired epilepsies" are defined as epilepsies which result from injury to the brain, including traumatic brain injury, stroke, infection, and brain tumor. CURE strongly encourages collaborative projects, specifically those that introduce investigators and expertise from fields outside of epilepsy.
Eligibility: This award is available to both established and early career investigators exploring cutting-edge approaches to curing epilepsy. International applicants are welcome. Researchers who serve on CURE’s Scientific Advisory Board are ineligible to apply for or sponsor a grant for the duration of their term. All materials must be submitted in English.
* Generally, early career investigators are university faculty at the assistant professor level (or hold an equivalent position in a non-university research organization). Established investigators are university faculty at the associate professor level or above.
Budget: Requests may be made for up to $250,000 over 2 or 3 years.
Letter of Intent: All applicants must submit a Letter of Intent (LOI). The LOI should succinctly outline the hypothesis to be tested, the specific aims and provide a brief description of the research plan. All LOIs are evaluated by scientific reviewers and the Research Review Board, with the final decisions as to who will be invited to submit formal proposals made by the CURE Board of Directors.
2013 FUNDING CYCLE
Deadline for Receipt of LOI: January 22, 2013
Full Application Invitations: March 1, 2013
Deadline for Receipt of Full Application: May 1, 2013
Award Announcement: July 2013
Earliest Project Start Date: August 1, 2013
All letters of intent must be submitted through proposalCENTRAL (https://proposalcentral.altum.com) by Tuesday, January 22, 2013 at 9:00pm, ET. In order to begin an application, applicants will need to create a professional profile, if one does not already exist.
2013 CURE Challenge Award
Posted: 19 Nov 2012 08:12 AM PST
2013 CURE Challenge Award
CURE promotes research that advances the search for a cure, and addresses the goal of “no seizures, no side effects.” Successful applicants for the Challenge Award should propose research in at least one of the following priority areas: the basic mechanisms of epileptogenesis or the multifaceted causes of epilepsy. We specifically encourage studies that may not be currently fundable by other agencies, such as the NIH, because of their preliminary or unconventional nature. CURE strongly encourages collaborative projects, specifically those that introduce investigators and expertise from fields outside of epilepsy.
Eligibility: This award is available to both established and early career investigators exploring cutting-edge approaches to curing epilepsy. Preference will be given to research addressing the more severe and refractory syndromes of epilepsy. International applicants are welcome. Researchers who serve on CURE’s Scientific Advisory Board are ineligible to apply for or sponsor a grant for the duration of their term. All materials must be submitted in English.
* Generally, early career investigators are university faculty at the assistant professor level (or hold an equivalent position in a non-university research organization). Established investigators are university faculty at the associate professor level or above.
Budget: Requests may be made for up to $250,000 over 2 or 3 years
Letter of Intent: All applicants must submit a Letter of Intent (LOI). The LOI should succinctly outline the hypothesis to be tested, the specific aims and provide a brief description of the research plan. All LOIs are evaluated by scientific reviewers and the Research Review Board, with the final decisions as to who will be invited to submit formal proposals made by the CURE Board of Directors.
2013 FUNDING CYCLE
Deadline for Receipt of LOI: January 22, 2013
Full Application Invitations: March 1, 2013
Deadline for Receipt of Full Application: May 1, 2013
Award Announcement: July 2013
Earliest Project Start Date: August 1, 2013
All letters of intent must be submitted through proposalCENTRAL (https://proposalcentral.altum.com) by Tuesday, January 22, 2013 at 9:00pm, ET. In order to begin an application, applicants will need to create a professional profile, if one does not already exist.
2013 CURE SUDEP Award
Posted: 19 Nov 2012 07:56 AM PST
2013 CURE SUDEP Award
Every year, it is estimated that up to 50,000 deaths occur in the United States from seizure-related causes including Sudden Unexpected Death in Epilepsy (SUDEP). There is an urgent need for more research to determine underlying mechanisms and causes of SUDEP so that the risk may be minimized and eventually eliminated. Accordingly, CURE has established a targeted research program to advance the study of SUDEP.
CURE seeks novel research projects that will address the goal of the prevention of SUDEP. This program awards seed grants to researchers submitting innovative proposals that will provide new directions for SUDEP research. We specifically encourage studies that may not be currently fundable by other agencies, such as the NIH, because of their preliminary or unconventional nature. CURE encourages collaborative projects; however, non-collaborative projects will be given equal consideration.
Eligibility: This award is available to both established and early career investigators exploring cutting-edge approaches to curing epilepsy. International applicants are welcome. Researchers who serve on CURE’s Scientific Advisory Board are ineligible to apply for or sponsor a grant for the duration of their term. All materials must be submitted in English.
* Generally, early career investigators are university faculty at the assistant professor level (or hold an equivalent position in a non-university research organization). Established investigators are university faculty at the associate professor level or above.
Budget: Requests may be made for up to $100,000 for 1 year.
Letter of Intent: All applicants must submit a Letter of Intent (LOI). The LOI should succinctly outline the hypothesis to be tested, the specific aims and provide a brief description of the research plan. All LOIs are evaluated by scientific reviewers and the Research Review Board, with the final decisions as to who will be invited to submit formal proposals made by the CURE Board of Directors.
2013 FUNDING CYCLE
Deadline for Receipt of LOI: January 22, 2013
Full Application Invitations: March 1, 2013
Deadline for Receipt of Full Application: May 1, 2013
Award Announcement: July 2013
Earliest Project Start Date: August 1, 2013
All letters of intent must be submitted through proposalCENTRAL (https://proposalcentral.altum.com) by Tuesday, January 22, 2013 at 9:00pm, ET. In order to begin an application, applicants will need to create a professional profile, if one does not already exist.
2013 Pediatric Epilepsies Award
Posted: 19 Nov 2012 07:47 AM PST
2013 Pediatric Epilepsies Award
There are many known epilepsy syndromes that occur in the pediatric population. These epilepsies are often debilitating and difficult to treat with currently available therapies. CURE seeks novel research projects of relevance to any or all of them, including: (1) the cellular, molecular, and systems-level understanding of the underlying pathogenic mechanisms; (2) investigations of the impact, natural history, and epidemiology; and (3) novel treatments which may impact progression of the disease. CURE strongly encourages collaborative projects, specifically those that introduce investigators and expertise from fields outside of epilepsy.
Eligibility: This award is available to both established and early career investigators exploring cutting-edge approaches to curing epilepsy. International applicants are welcome. Researchers who serve on CURE’s Scientific Advisory Board are ineligible to apply for or sponsor a grant for the duration of their term. All materials must be submitted in English.
* Generally, early career investigators are university faculty at the assistant professor level (or hold an equivalent position in a non-university research organization). Established investigators are university faculty at the associate professor level or above.
Budget: Requests may be made for up to $250,000 over 2 years.
Letter of Intent: All applicants must submit a Letter of Intent (LOI). The LOI should succinctly outline the hypothesis to be tested, the specific aims and provide a brief description of the research plan. All LOIs are evaluated by scientific reviewers and the Research Review Board, with the final decisions as to who will be invited to submit formal proposals made by the CURE Board of Directors.
2013 FUNDING CYCLE
Deadline for Receipt of LOI: January 22, 2013
Full Application Invitations: March 1, 2013
Deadline for Receipt of Full Application: May 1, 2013
Award Announcement: July 2013
Earliest Project Start Date: August 1, 2013
All letters of intent must be submitted through proposalCENTRAL (https://proposalcentral.altum.com) by Tuesday, January 22, 2013 at 9:00pm, ET. In order to begin an application, applicants will need to create a professional profile, if one does not already exist.
Call for Nominations: 2013 American Society for Reproductive Medicine Distinguished Researcher Award
Posted: 19 Nov 2012 07:22 AM PST
Call for Nominations: 2013 American Society for Reproductive Medicine Distinguished Researcher Award
Nominations are being sought for the 2013 ASRM Distinguished Researcher Award.
This award recognizes a member of the American Society for Reproductive Medicine who has made outstanding contributions to clinical or basic research in reproduction published during the previous 10 years. The recipient will have demonstrated sustained long-term commitment to advancing the frontiers of research in reproductive sciences and educating future scholars in the field.
Nominations may be submitted to Andrew R. La Barbera, Ph.D., ASRM Scientific Director, by members of the Society before June 1, 2013. Each nomination must include the nominee’s curriculum vitae, bibliography and summary of research and educational accomplishments in the field of reproductive medicine and biology, and must be accompanied by letters of support from at least two additional members of the Society. The recipient will be selected by the Executive Committee and notified by August 1, 2013. Previous nominees will be considered.
The recipient will be recognized as the ASRM Distinguished Researcher Awardee by presentation of a plaque at the Annual Meeting in Boston. In addition, the recipient will be provided with an honorarium of $1,500, which will be presented after the recipient presents a lecture at the Annual Meeting of the Society for the Study of Reproduction in Montreal, Canada in July 2014.
American Society for Reproductive Medicine Research Grant Program
Posted: 19 Nov 2012 07:06 AM PST
American Society for Reproductive Medicine Research Grant Program
The purpose of the ASRM Research Grant Program is to foster the development of innovative research, to facilitate the research endeavors of new investigators, and to provide bridge funding for projects that advance the Society’s mission. Proposals from junior faculty, particularly those in their first three years of faculty appointment, will receive priority. The ASRM Research Grants, which are funded by the ASRM, are reviewed by the ASRM Research Committee and awarded by the Board of Directors. Grants in amounts of $10,000 to $50,000 will be considered on an annual basis. A total of $200,000 is available for 2013. Funds are available for project expenses, technical assistance, patient expenses, research supplies and durable laboratory equipment. Up to ten percent (10%) of funds may be used for indirect costs or institutional overhead in circumstances deemed to be extraordinary by the Research Committee. Innovative projects or projects that have previously been funded by other sources and are in need of bridge funding are appropriate. Research grant funds may be expended over a 2-year time interval. If residual funds remain after 2 years, the principal investigator can apply for a no-cost extension. An individual is eligible to receive only one grant. Grants may be renewed under extraordinary circumstances, such as may be necessary to sustain an ongoing activity of importance to the Society.
REQUIREMENTS
Recipients of an ASRM Research Grant may also have other grants contributing to the funding of their project; however, the additional funding amounts must be noted on the grant application. A progress report and a financial report on the work sponsored by the ASRM Research Grant are required annually and within 60 days of the completion date of funding for the project. The final report should include a summary of the project and an accounting of funds spent, be signed by the recipient of the award and the institutional grants officer, and submitted to the ASRM office. All unused funds will be returned to the ASRM at the completion of the project unless additional time has been approved by no-cost as described above, or if the project has not been initiated at the end of the first year. An abstract should be submitted for consideration at an ASRM Annual Meeting either prior to or after completion of the project.
ELIGIBILITY
To be eligible for an ASRM Research Grant, the Candidate/Principal Investigator must:
Have earned an M.D. and/or Ph.D. and/or D.O. and/or D.V.M. degree or their equivalents.
Be an independent investigator who has completed his/her training; clinical and research fellows are not eligible.
Have been an active member of ASRM for at least one year prior to submission of the application.
APPLICATION
There is no application form. The application consists of the following eight items in this order:
1. Cover sheet - including title of research proposal, applicant’s name and degree(s), address, telephone, fax, and email.
2. Research Proposal – the description of the research project must be presented in NIH format using six pages or less and including bibliography. Use Arial, Helvetica, Palatino Linotype, or Georgia typeface; a font size of 11 points or larger; no more than 15 characters per inch; no more than six lines per inch; one-half inch margins.
3. A one-page budget should be prepared and signed by the applicant and by the Department Chair (see attached budget template) and the appropriate institutional official. Recipients may have other grants that contribute to funding of their project, and notation of this funding must be included in the application budget.
4. Applicable institutional certifications of regulatory compliance, e.g., human subjects, animals, biohazards, radioactive materials, recombinant DNA, etc.
5. Statement of Career Goals – briefly list and/or describe career goals if the applicant is a new investigator.
6. Curriculum Vitae – this should include basic personal data, educational background, past and present positions, honors, achievements, and publications; limited to three pages; an NIH biosketch is acceptable.
7. Letter of Recommendation from Division Director or Department Chair – signed letter on company/organizational letterhead.
8. Letter of Intent from Chair of the Department – this letter should state that the award money will only be allocated for the items noted in the budget and should affirm that the appropriate time will be allotted for completion of the research by the faculty member and that appropriate facilities will be available for the grant recipient to carry out the project.
SELECTION
Selection is based primarily on the scientific merit of the proposed study. The Research Committee may utilize the review services of non-Committee experts if necessary to ensure a competent and balanced review. Members of this Committee will recuse themselves from the selection process for a given year if any proposals for that year involve members of their institutions. Projects proposed by new investigators, highly innovative studies, and studies of high scientific merit requiring bridge funding will have priority. Evaluation of the proposals by the ASRM Research Committee will include the availability of resources to conduct the proposed study and the identification of a principal investigator who can offer an appropriate environment for the pursuit of the proposed project. The recipient is required to attend the ASRM Annual Meeting. Members of the Executive Committee are not eligible to submit applications and they will recuse themselves from this review if any of the proposals for that year involve their institutions. In addition the ASRM Research Committee will review the progress reports and financial reports on the work sponsored by the ASRM research grants annually and upon completion of funding for the project. Members of the Research Committee will recuse themselves from the review of reports for any project that involves their institutions of employment. The applicant will be notified of the decision by June 1, 2013 and funding will commence July 1, 2013.
DEADLINE FOR RECEIPT OF APPLICATIONS IS MARCH 1, 2013.
You will receive an email acknowledgement when your application is received. If you have not received an acknowledgement by March 15, 2013 please contact: Ms. Cherie Holverstott, ASRM, 205-978-5000 x155, Fax 205-978-5005, or email [log in to unmask]
Request for Proposals: Prescription Drugs and Drug Combinations Found in Older Drivers
Posted: 07 Nov 2012 08:11 AM PST
Request for Proposals: Prescription Drugs and Drug Combinations Found in Older Drivers
Deadline: 12:00PM Eastern Time Monday November 19, 2012
Objective
The AAA Foundation for Traffic Safety is seeking proposals for research that would identify the prescription and over the counter medications, and combinations thereof, most commonly used by older drivers involved in motor vehicle collisions. Drugged driving is thought to be increasingly prevalent, even among individuals taking medication as prescribed by their doctors. The older adult population (ages 65+), as well as that of older drivers specifically, is rapidly growing, thereby elevating the importance of older driver safety in traffic safety and public health. Identifying the most common medications (versus large categories of drugs) associated with crashes among this population will help the medical community and others to provide better guidance to consumers and adjust medication regimens for safer driving practices.
Email the staff at [log in to unmask]
Administrative Office:
607 14th Street NW
Suite 201
Washington, DC 20005
Tel: 202-638-5944
Fax: 202-638-5943
Request for Proposals: Developing a Long-Term Prospective Cohort Study to Better Understand Senior Drivers
Posted: 07 Nov 2012 08:01 AM PST
Request for Proposals: Developing a Long-Term Prospective Cohort Study to Better Understand Senior Drivers
Deadline: 12:00 PM Eastern Time Monday, November 19, 2012
Objective
The AAA Foundation for Traffic Safety is seeking proposals for research that would track a large cohort of relatively healthy older drivers for an extended period of time and study a range of safety and mobility issues pertaining to this demographic. As envisioned, this project would follow a number of drivers ages 65+ for 5-10 years (at a minimum), and examine issues related to, among other things, medications, medical conditions, physical impairments, visual and cognitive functions, driving patterns, and exposure. Also of key interest will be the circumstances surrounding driving cessation (e.g, self-regulation, family intervention, license revocation, crash involvement, etc.), and mobility decisions and options for older Americans who no longer drive.
While common in behavioral and health research, very few studies of this nature that follow individuals over time have yet to be conducted for the explicit purpose of evaluating driver fitness and safety outcomes. Ultimately, the project’s goal is to gain insight into safety considerations facing today’s older driver population, and to generate an extensive data and knowledge base that will fuel future research and decision-making regarding older driver safety and mobility.
Background
During the next two decades, more than 78 million baby boomers will join the “senior citizen cohort.” According to the U.S. Census, about 10,000 people will turn 65 every day, with upwards of 85 percent of these newly minted seniors expected to still hold driver licenses. While much is known about senior drivers, the baby boomer generation will potentially face a very different driving experience than their parents did, due to continued developments in vehicle safety technologies and roadway infrastructure design, as well as significant medical developments and health and lifestyle changes.
These variables make it difficult to accurately predict future safety and mobility needs for this generation. As such, research is needed in order to provide insights that will help address the needs of this burgeoning population of people in their 70s, 80s and 90s. The majority of older driver research to date has focused on outcomes related to crash involvement and risk factors associated with such incidents. Other research, including studies of driving cessation, near crashes and driving difficulty, has been less extensive. Specifically, the effects of changes in laws, prescription drugs, chronic medical conditions, physical impairments, visual acuity and cognitive functions on driving, driving cessation and mobility after driving need to be better understood.
Scope of the Project and Study Population
This project will require the establishment of a mechanism for enrolling and tracking a large number (to be specified in your proposal) of drivers over several years. Ultimately, we are interested in gaining insight into a variety of questions related to older drivers, which could potentially include (but are not limited to):
- What medications are most associated with driving performance and behavior?
- What are the true risk factors pertaining to older drivers, both in terms of hazards posed to them and dangers they pose to others?
- What protective factors are observed with regards to older drivers (e.g., higher seat belt usage, lower alcohol prevalence, etc.)?
- How does a driver’s behavior behind the wheel change as different medical, mental, and physical conditions progress?
- How do these drivers self-regulate their driving to account for declines in vision or motor functions?
- What are the major reasons that older Americans stop driving?
- What happens after older adults turn in the keys?
o What decisions do they make with regards to transportation?
o What options do they have?
o How is overall mobility impacted?
- What happens to crash-involved seniors?
o Are they likely to stop driving?
o Do they resume driving after a period of time?
- Are older drivers prematurely turning in the keys despite still being able to operate a vehicle in a safe manner?
- How does this generation of drivers interact with in-vehicle technologies?
In your proposal, please detail how your project would address two of the above questions, including 1) the question pertaining to medications, and 2) a question of your choosing.
Within the framework of a prospective cohort study, you are free to propose a variety of data collection and analysis methods and justify why they would be appropriate avenues for answering the questions listed above, along with other questions you may propose to answer. These may include administering surveys, collecting exposure data, or employing naturalistic data collection tools (e.g., DriveCam or “black boxes”), among other things. The study subjects should be a representative sample of drivers ages 65 and older who own or have regular access to a vehicle, and who drive at least once per week. These drivers should be relatively healthy at the outset of the study (medical conditions that may develop during the study will be of interest), and must be willing to take part in in-person examinations for the study at least once per year. Participants will be compensated.
Crucially, please note that the overarching objective of this study is to learn how we can help older drivers retain their licenses for as long as they safely can, and promote comfortable and convenient transportation alternatives afterwards. This research is intended to help us better understand the safety needs of older drivers, and to stimulate improvements in mobility options for those who no longer drive; it is not intended to establish thresholds for turning in the keys.
Email the staff at [log in to unmask]
Administrative Office:
607 14th Street NW
Suite 201
Washington, DC 20005
Tel: 202-638-5944
Fax: 202-638-5943
Regards,
Heather Johnston, MA
Assistant Director and Information Coordinator
Office for the Advancement of Research & Scholarship (OARS)
Miami University
Roudebush Hall, Room 102
501 E High Street
Oxford, OH 45056
513-529-1760
513-529-3762 (fax)
[log in to unmask]
|
